Genetic testing for breast cancer is to be covered as a preventive service under the US Affordable Care Act, reports MyHealthNewsDaily. A clarification from the Department of Health and Human Services, the Department of Labor, and the Department of Treasury says that asymptomatic, high-risk women — typically with a family history of breast or ovarian cancer — will be able to get tested for the breast cancer risk genes BRCA1 and BRCA2 with no co-pay.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.